A year and a half later, the team has reported – again in Nature ("Targeting protein-ligand neosurfaces with a generalizable deep learning tool") – an exciting advancement of this technology. They ...
HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence for drug design, announced today that it has secured the #1 global ranking for new U.S.
In 2023, scientists in the joint School of Engineering and School of Life Sciences Laboratory of Protein Design and Immunoengineering (LPDI), led by Bruno Correia, published in Nature a deep-learning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results